New Method of Treating Multiple Sclerosis
نویسنده
چکیده
Case study Female teacher, born 1963. First episode of multiple sclerosis (MS) in autumn 2003, medical diagnosis in spring 2004, Prednisone treatment, 7 week course. Since then Rebif® 44 injected 3 times per week, numerous side effects. Consequently considered possibilities of naturopathic treatment, initially magnetic field therapy, symptoms began to improve. After switching to energised inhaled air immediate improvement in mobility, patient increasingly felt better, long-term state of health significantly improved with no onset (felt ready to tackle anything). To provide more detail, various symptoms since autumn 2003 which were attributed to MS in 2004 and whose frequency and intensity reduced considerably since beginning Airnergy therapy (sensitivity on lowering the head, tingling in fingertips, no reaction to pinching and pricking in upper abdomen, legs tired easily when climbing stairs, blurred vision, disorders of the bladder/intestines, problems concentrating, permanently tired, mood fluctuations).
منابع مشابه
P 64: Micro-Rna Disorder and Multiple Sclerosis
Noncoding ribonucleic acids micro-RNA is involved in the regulation of gene expression have major roles in the post-transcriptional level. A micro-RNA alone several causes down regulation of mRNA transcript of the target. Thus, small changes in the expression of a micro RNA may lead to significant changes in gene expression are different. Micro- RNA as key regulators of immune cell lineage diff...
متن کاملSafety and effectiveness assessment of intravenous immunoglobulin in the treatment of relapsing-remitting multiple sclerosis: A meta-analysis
Background: Intravenous immunoglobulin (IVIG) is an established treatment of immune mediated demyelinating neuropathy including Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Recent trials suggest its efficacy in treating relapsing- remitting multiple sclerosis. IVIG exerts a number of effects, which may be beneficial in treating multiple sclerosis (MS): R...
متن کاملSensory-Neural Hearing Loss as an Early Rebound Relapse after Fingolimod Cessation in Multiple Sclerosis
Introduction: Multiple sclerosis (MS) is a lifelong disease of the brain and spinal cord. Fingolimod is an oral drug which modulates the S1P receptor and is used for relapsing remitting form of MS and can causes rebound activity if it is ceased even in a short period of washout time. Case Report: Here, we introduce a young girl, a known case of MS, who developed revers...
متن کاملFatigue Severity and Sleep Disorders Among Patients With Multiple Sclerosis: A Cross-sectional Study From Iran
Background: Multiple sclerosis (MS) is the most prevalent autoimmune chronic disease globally. The current study was conducted to determine the relationship between fatigue severity and circadian rhythm sleep disorders among Iranian MS patients. Methods: The statistical population of this cross-sectional study included MS patients who were members of the MS Association in Khorramabad City, so...
متن کاملReview of New Methods of Diagnosis and Treatment of Multiple Sclerosis
Multiple sclerosis (MS) is a demyelinating process involving mainly the white matter of central nervous system. The clinical diagnosis generally rests on two features of the illness: A. A history of fluctuations in the clinical course. B. A physical examination consistent with that of multiple lesionsjinllheiwhite matter o,f the central nervous system. No specific laboratory test is cur...
متن کاملO 9: Immunomodulatory Effects of Neural Stem Cell on Multiple Sclerosis: A Systematic Review
Multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), are chronic inflammatory demyelinating disorders of central nervous system (CNS). While the cause is unclear, the fundamental mechanism is thought to be destruction of myelin sheaths of neurons through immune system. One of the approaches being proposed in EAE therapy is neural stem cells (NSCs) trans...
متن کامل